Analysis Article • Aug 19
Have your own idea? Try our Stock Screener
Hong Kong (HSI) Pharma Industry Analysis
UpdatedAug 25, 2026
DataAggregated Company Financials
Companies44
- 7D0.2%
- 3M0.2%
- 1Y-24.2%
- YTD-14.4%
Over the last 7 days, the Pharma industry has risen 2.6%, driven by gains from Sino Biopharmaceutical of 16%. During this same period, the Hansoh Pharmaceutical Group underperformed, falling 5.7%. However, the industry is down 21% over the past year. Earnings are forecast to grow by 13% annually.
Industry Valuation and Performance
Has the Hong Kong Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 25 Aug 2026 | HK$688.7b | HK$536.9b | HK$32.4b | 13.3x | 21.3x | 1.3x |
| Thu, 23 Jul 2026 | HK$689.4b | HK$522.3b | HK$28.1b | 14.3x | 24.5x | 1.3x |
| Sat, 20 Jun 2026 | HK$618.9b | HK$522.1b | HK$29.3b | 12.7x | 21.1x | 1.2x |
| Mon, 18 May 2026 | HK$709.5b | HK$519.5b | HK$29.7b | 14.4x | 23.9x | 1.4x |
| Wed, 15 Apr 2026 | HK$786.0b | HK$517.8b | HK$30.3b | 15.2x | 26x | 1.5x |
| Fri, 13 Mar 2026 | HK$750.9b | HK$500.5b | HK$30.5b | 12.4x | 24.6x | 1.5x |
| Sun, 08 Feb 2026 | HK$813.5b | HK$495.1b | HK$30.3b | 13.3x | 26.8x | 1.6x |
| Tue, 06 Jan 2026 | HK$794.3b | HK$490.5b | HK$30.1b | 13.2x | 26.4x | 1.6x |
| Thu, 04 Dec 2025 | HK$814.1b | HK$485.0b | HK$29.8b | 13.6x | 27.4x | 1.7x |
| Sat, 01 Nov 2025 | HK$786.8b | HK$480.7b | HK$30.1b | 13.8x | 26.2x | 1.6x |
| Mon, 29 Sep 2025 | HK$768.8b | HK$478.6b | HK$30.6b | 13.4x | 25.2x | 1.6x |
| Wed, 27 Aug 2025 | HK$810.4b | HK$477.0b | HK$30.7b | 12.8x | 26.4x | 1.7x |
| Fri, 25 Jul 2025 | HK$723.6b | HK$476.9b | HK$29.1b | 12.2x | 24.8x | 1.5x |
| Sun, 22 Jun 2025 | HK$617.3b | HK$476.8b | HK$28.8b | 11.6x | 21.4x | 1.3x |
| Tue, 20 May 2025 | HK$520.5b | HK$475.2b | HK$29.0b | 10.2x | 17.9x | 1.1x |
| Thu, 17 Apr 2025 | HK$467.8b | HK$466.1b | HK$28.6b | 10x | 16.4x | 1x |
| Sat, 15 Mar 2025 | HK$464.1b | HK$465.4b | HK$32.0b | 9.1x | 14.5x | 1x |
| Mon, 10 Feb 2025 | HK$421.8b | HK$462.0b | HK$31.9b | 8.7x | 13.2x | 0.9x |
| Wed, 08 Jan 2025 | HK$411.7b | HK$459.0b | HK$31.7b | 8.4x | 13x | 0.9x |
| Fri, 06 Dec 2024 | HK$442.1b | HK$462.9b | HK$31.9b | 8.2x | 13.9x | 1x |
| Sun, 03 Nov 2024 | HK$448.5b | HK$471.5b | HK$32.7b | 8.2x | 13.7x | 1x |
| Tue, 01 Oct 2024 | HK$498.3b | HK$477.7b | HK$33.1b | 7.9x | 15x | 1x |
| Thu, 29 Aug 2024 | HK$443.1b | HK$467.9b | HK$32.6b | 7.8x | 13.6x | 0.9x |
| Sat, 27 Jul 2024 | HK$422.3b | HK$458.7b | HK$32.5b | 7.5x | 13x | 0.9x |
| Mon, 24 Jun 2024 | HK$446.5b | HK$462.1b | HK$33.8b | 7.8x | 13.2x | 1x |
| Wed, 22 May 2024 | HK$475.2b | HK$462.9b | HK$33.7b | 8.7x | 14.1x | 1x |
| Fri, 19 Apr 2024 | HK$426.9b | HK$464.6b | HK$33.8b | 7.4x | 12.6x | 0.9x |
| Sun, 17 Mar 2024 | HK$468.3b | HK$470.3b | HK$33.3b | 7.7x | 14x | 1x |
| Tue, 13 Feb 2024 | HK$410.1b | HK$470.9b | HK$33.6b | 6.6x | 12.2x | 0.9x |
| Thu, 11 Jan 2024 | HK$468.4b | HK$472.0b | HK$33.7b | 7.8x | 13.9x | 1x |
| Sat, 09 Dec 2023 | HK$471.9b | HK$472.0b | HK$33.7b | 7.4x | 14x | 1x |
| Mon, 06 Nov 2023 | HK$489.5b | HK$469.1b | HK$31.9b | 6.9x | 15.4x | 1x |
| Wed, 04 Oct 2023 | HK$436.3b | HK$469.6b | HK$31.6b | 6.7x | 13.8x | 0.9x |
| Fri, 01 Sep 2023 | HK$429.1b | HK$454.8b | HK$30.1b | 7.6x | 14.2x | 0.9x |
Price to Earnings Ratio
14.2x
Current Industry PE
- Investors are optimistic on the Hong Kong Pharmaceuticals industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 21.7x which is higher than its 3-year average PE of 18.7x.
- The industry is trading close to its 3-year average PS ratio of 1.2x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 5.7% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Trends
Which industries have driven the changes within the Hong Kong Healthcare industry?
| HK Market | 1.35% | |
| Healthcare | 1.65% | |
| Pharma | 0.15% | |
| Pharma | 0.15% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 1177 Sino Biopharmaceutical | HK$5.58 | 16.0% +HK$13.7b | -33.3% | PE35.7x | |
| 1093 CSPC Pharmaceutical Group | HK$9.40 | 7.3% +HK$7.3b | -13.4% | PE12.4x | |
| 6887 Sunshine Lake Pharma | HK$38.58 | 5.0% +HK$1.0b | -25.8% | PE69.9x | |
| 3933 United Laboratories International Holdings | HK$8.95 | 2.6% +HK$443.9m | -46.8% | PE7.3x | |
| 2186 Luye Pharma Group | HK$2.11 | 2.7% +HK$219.7m | -43.3% | PE11.7x |